InvestorsHub Logo
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: ghmm post# 1171

Thursday, 01/03/2013 3:22:08 PM

Thursday, January 03, 2013 3:22:08 PM

Post# of 1367

Does the lack of a complete dose response cause you to be more cautious especially with your other point about placebo crossovers?

The drug is an A3 adenosine receptor agonist and sounds like the high dose induced desensitization of the receptor. I have no biological explanation to the too quick placebo response after crossover.

I didn't see them listed in the JP Morgan agenda

I know you cannot read Hebrew but you can see 'JP Morgan' in the 7th line in their PR here:

http://www.canfite.com/upload/2012-12-30%20Psoriasis%20additional%20analysis%20%20-%20Hebrew.pdf

I suppose they will set meetings with potential investors there, so nothing you can listen to. Come over if you wanna have a sunny week plus a meeting with the company smile

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.